Researcher Dr Lewis Francis welcomed back to share expertise at virtual summit.

Swansea University research into therapeutic treatments for ovarian cancer will be highlighted to a global audience at a virtual online conference next week.

Associate professor Dr Lewis Francis, of the University’s Medical School, has been invited back to join the line-up of featured speakers at the SelectScience Virtual Biopharmaceuticals Summit on Tuesday, November 9.

He is part of the Reproductive Biology and Gynaecological Oncology Research Group (RBGO) and leads the group’s biophysics and epigenetics research programmes.

Dr Francis will present on some exciting research, primarily focused on new nanoscale drug delivery approaches tailored toward the challenges of drug delivery in ovarian cancer.

He said: “The work is the product of our ongoing collaboration with Tenovus Cancer Care and is an exciting example of cross disciplinary research being conducted in the group and by the Centre for NanoHealth.

The summit will bring together scientists from across the world to explore the major new developments in biopharmaceutical research. Dr Francis was a speaker at the successful inaugural event last December and was eager to take part again.

He said: “The global pandemic has affected academic and researcher mobility, making it more difficult to share ideas and bring the community together.

“The boom in virtual summits and conferences however has transcended this problem and made us all comfortable in the virtual space.

“It’s exciting for us to update on our research and interact with scientists again, following up on a successful and engaging event last year.“

Topics on the free-to-attend summit’s agenda include advances in bioanalysis, cell and gene therapy, automation, COVID-19 research and nanomedicines. 

View the speaker line-up and reserve a place 

Share Story